Articles On IDT Australia (ASX:IDT)

Title Source Codes Date
Weed Week: California legalises hemp and Aussie medicinal cannabis use hits all-time high

Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow...

Stockhead IDT 5 days ago
IDT Australia (ASX:IDT) signs manufacturing deal with Monash University

IDT Australia (IDT) partners with the Monash University to produce a drug product for an mRNA COVID-19 receptor binding domain vaccine clinical trial This government-funded project aims to create Australia’s first locally manufactured cGMP...

themarketherald.com.au IDT 6 days ago
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

Stockhead IDT 3 weeks ago
Closing Bell: ASX retreats, led by 2pc drop in energy

Once again the energy sector determined the direction of the market but unlike yesterday where it gained, today it finished in the red. The ASX 200 retreated 0.27% to close at 7,417 points, although the ASX Emerging Companies Index rose 1.3...

Stockhead IDT 1 month ago
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

Stockhead IDT 1 month ago
Here’s why the IDT Australia (ASX:IDT) share price is up 75% in a month.

The IDT Australia Limited (ASX: IDT) share price has slipped into the red during early trade on Tuesday. Despite this, IDT shares have been a major performer on the Australian broad indices lately. Whereas the S&P/ASX 200 Index (ASX:...

Motley Fool IDT 1 month ago
August ASX Winners Column: Reporting season failed to get investors excited, but coal, lithium and COVID battlers did

August was another month of lockdown for much of Australia’s East Coast but lockdowns and even a 2% drop in the middle of the month couldn’t stop the ASX from producing another winners list. The ASX 200 ultimately finished August 1.9% highe...

Stockhead IDT 1 month ago
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Stockhead IDT 1 month ago
Hot Money Monday: ASX large caps run hot in a bumper earnings season

Hot Money Monday is typically the domain of ASX small caps, but this week saw plenty of larger companies near the top end of the list as investors responded to some reporting season surprises. Each week, Stockhead recaps ASX stocks that are...

Stockhead IDT 1 month ago
Closing Bell: ASX closes slightly lower, still notches up weekly gain

The ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday. The ASX Emerging Companies Index lost 0.57% to close at 2,285 points. The best sector was industrials which gained 1.07%. Tech and consume...

Stockhead IDT 1 month ago
Weed Week: Cannabis trade shows and Europe imports medicinal marijuana

Virginia is the latest US state to legalise marijuana and they’re celebrating with the first annual CannaFest VA cannabis trade show on September 19. The event will feature a concert, and a custom car and motorcycle exhibition but no, you c...

Stockhead IDT 1 month ago
Seven stunning ASX healthcare shares to keep tabs on

Highlights  ASX-listed healthcare companies rarely fail to bring joy to the market participants, with a few of them providing outstanding returns in the last couple of months. Rhinomed, IDT Australia, and Prescient lead the way with ou...

Kalkine Media IDT 1 month ago
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

Stockhead IDT 1 month ago
IDT Australia (ASX: IDT) share price surges 16% on vaccine government talks

The IDT Australia Limited (ASX: IDT) share price has soared into the green during early trade on Monday. IDT shares are on the move as the pharmaceuticals company gave a key update. Let’s investigate further. What did IDT announce? IDT...

Motley Fool IDT 1 month ago
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough

IDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with the Australian Government to potentially assist with the production of a COVID-19 vaccine. There was recent media interest surrounding a mR...

Stockhead IDT 1 month ago
10 at 10: These ASX stocks are the first to shine this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead IDT 1 month ago
Hot Money Monday: BNPL gets the shivers, while Ikwezi Mining runs hot as coal makes a comeback

Ikwezi Mining (ASX:IKW) topped the latest Running Hot list with a 14-day RSI of 82, after two straight weeks where lithium stocks dominated. Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength I...

Stockhead IDT 1 month ago
Closing Bell: ASX down 2.2pc for the week

Another red day for the ASX to close out the week. The ASX 200 closed 0.05% down from yesterday at 7,461 points, 2.2% lower than a week ago. The ASX Emerging Companies Index meanwhile dropped 2.09%, closing at 2,187 points which is over 5%...

Stockhead IDT 1 month ago
Closing Bell: ASX retreats for the third day in a row

While today was a better day for the ASX than the past two days, the bourse still finished slightly in the red After dropping by nearly 1% yesterday, the ASX 200 traded slightly higher for most of the day but closed 7,502 points, which was...

Stockhead IDT 2 months ago
Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

The IDT Australia Limited (ASX: IDT) share price is shooting 25% higher after The Sydney Morning Herald (SMH) reported the company is seeking to work with the federal government to produce mRNA vaccines in Australia. At the time of writing...

Motley Fool IDT 2 months ago
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Stockhead IDT 2 months ago
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025

Massachusetts based cannabis operator MariMed has just announced a joint collaboration with the legendary Boston ice cream brand Emack & Bolio’s® to create a line-up of cannabis-infused vegan and dairy ice cream. The ice cream will cont...

Stockhead IDT 2 months ago
Trading Places: Who’s betting on return to office stocks?

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Stockhead IDT 2 months ago
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Stockhead IDT 2 months ago
Weed Week: Cannabis business degrees, cornering Germany’s €200M market and Hanks Kerchiefs hits stores

The Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business mana...

Stockhead IDT 2 months ago
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Stockhead IDT 2 months ago
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

Stockhead IDT 3 months ago
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead IDT 3 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Stockhead IDT 3 months ago
10 at 10: These ASX stocks have given shareholders something to cheer about this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead IDT 3 months ago
IDT Australia progresses talks to provide manufacturing capabilities for Australian COVID-19 vaccine candidate

If discussions continue, IDT is poised to provide its current good manufacturing process (cGMP) to help create a new type of COVID-19 vaccine on Australian soil.

Proactive Investors IDT 3 months ago
Why the IDT Australia (ASX:IDT) share price is storming 19% higher today

The IDT Australia Limited (ASX: IDT) share price has been a very strong performer on Tuesday. In late afternoon trade, the Australian pharmaceutical manufacturing company’s shares are up over 19% to 40 cents. This means the IDT Australia s...

Motley Fool IDT 3 months ago
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US

The US cannabis sector received a big lift after Amazon announced that job applicants at its offices and warehouses will no longer be drug-tested for marijuana use. Delivery drivers, however, will still be tested. The company also said it w...

Stockhead IDT 4 months ago
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Stockhead IDT 4 months ago
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks

There was plenty of action in the US regulatory front within the cannabis sector this week. A couple of major legislations during the week could potentially shake up the US cannabis industry. The Marijuana Opportunity Reinvestment and Expun...

Stockhead IDT 4 months ago
Invion led a group of ASX cancer stocks up after promising news

It was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies releasing seperate announcements that sent their share prices higher. Cancer therapy stocks Invion (ASX:IVX), Immutep (ASX:IMM), and Imugene (ASX...

Stockhead IDT 4 months ago
Weed Week: Europe or North America, where’s the place to be for ASX cannabis stocks?

In 2021, which of Europe and North America is the place to be for ASX cannabis stocks?   The case for Europe A few years ago there would’ve been no question that it was North America with Canada legalising recreational cannabis as well as h...

Stockhead IDT 4 months ago
Weed Week: Finally, a cannabis drug is on Australia’s Pharmaceutical Benefits Scheme

A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav...

Stockhead IDT 5 months ago
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months

ASX pot stocks have run hot in recent months but eight in particular have been particularly rewarding for shareholders. Many pot stocks ran cold prior to COVID-19 as regulatory progress stalled and global markets didn’t take off. Australia...

Stockhead IDT 5 months ago
A glance at 2 ASX penny shares  - MGC Pharmaceuticals and archTIS

Summary Australian players MGC Pharmaceuticals and ArchTIS limited were under the spotlight following recent crucial developments. Biopharma player MGC Pharma announced the acquisition of MediCaNL that is likely to deliver cost savings...

Kalkine Media IDT 5 months ago
Weed Week: 4/20 can’t help ASX cannabis companies

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

Stockhead IDT 5 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

Stockhead IDT 5 months ago
Emyria raises AU$5 Mn to support drug registration, product portfolio expansion

Summary Emyria has received firm commitments in a well-supported placement to raise AU$5 million. The Company will use these funds to advance drug development and develop its product pipeline. The proceeds would also support the initi...

Kalkine Media IDT 5 months ago
Why are Australian healthcare shares Telix and Ramsay trending today?

Source: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the launch of NOBLE Registry of its prostate cancer imaging agent. Global healthcare company Ramsay Health Care confirms the funding guarantee arr...

Kalkine Media IDT 6 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead IDT 6 months ago
AstraZeneca rollout in jeopardy? The ASX’s COVID vaccine maker and wannabe seem immune

Shares in CSL (ASX:CSL) and IDT Australia (ASX:IDT) both fell early after the latest setback to Australia’s COVID vaccination program – or specifically the AstraZeneca vaccine. The Morrison government had aimed to vaccinate Australians by O...

Stockhead IDT 6 months ago
Weed Week: Australian medical cannabis prescriptions are soaring

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

Stockhead IDT 6 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

Stockhead IDT 6 months ago
March Winners Column: Oil is FINALLY on the boil

March got off to a rough start, with ASX small caps suffering their worst week since October and the Small Ords Index falling into the red on the year. But it got better. US punters received another stimmy cheque in the mail from President...

Stockhead IDT 6 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

Stockhead IDT 6 months ago